Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
<p><strong>Background</strong></p> Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patien...
| Hlavní autoři: | , , , , , , |
|---|---|
| Další autoři: | |
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Massachusetts Medical Society
2021
|